Overview

Immune Response to Shingles Vaccination

Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV).
Phase:
Phase 4
Details
Lead Sponsor:
University of Washington
Collaborator:
Merck Sharp & Dohme Corp.